BSX Stock Boston Scientific Corporation
STRONG BUY US · NYSEStructural medtech growth and procedure recovery provide durable earnings momentum with analyst support.
Future value: $58.00 (+27.25%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Strong Buy consensus and recent analyst Buy reiteration.
- ▸Above 50-day MA (+0.36%)
- ▾Near 52-week low (6.5% of range)
- ▸~27% upside to price target
Is BSX a buy right now?
Trend: BSX is trading above the 50-day average (+0.35%), RSI 44 — neutral momentum, with a 3-month return of -1.04%.
Valuation & quality: Boston Scientific Corporation trades on a trailing P/E of 18.5, forward P/E 13.5, PEG 0.64, price-to-book 2.65; fundamentals show net margin 17.5%, return on equity 15.3%, revenue growth 7.5% year on year.
Analyst consensus: 28 analysts have a mean 12-month price target of $57.82 (+26.9% vs the last close; range $44.00 – $78.00), consensus rating “buy”.
Our screen: STRONG BUY (score 4) — Structural medtech growth and procedure recovery provide durable earnings momentum with analyst support.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -18.30% | -8.20% | -16.10% | -11.70% | +9.50% | +3.40% | -9.60% | +4.40% |
Fundamentals
Analyst price target
Technical signals
About Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Sector: Healthcare · Industry: Medical Devices · United States · 59,000 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.